McKesson (MCK) closed at $803.37 in the latest trading session, marking a -1.1% move from the prior day.

zacks.com - 2026-07-14 19:01:10

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outlook article.

zacks.com - 2026-07-14 04:36:12

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positioned to generate wealth for investors amid improving industry prospect.

zacks.com - 2026-07-13 13:40:24

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

zacks.com - 2026-07-09 10:31:07

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-07-08 10:01:12

McKesson (MCK) closed the most recent trading day at $807.33, moving +2.95% from the previous trading session.

zacks.com - 2026-07-07 19:01:15

McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

zacks.com - 2026-07-06 13:11:09

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.

fool.com - 2026-07-06 13:09:01

McKesson (MCK) is rated a buy, offering capital growth and dividend potential, underpinned by robust top-line and EPS growth. MCK's diversified portfolio, role in oncology and collaboration with big pharma names like AbbVie, and investment-grade Fitch rating support its investment case despite negative equity. Valuation appears compelling, with MCK trading at a forward earnings multiple of ~18x and estimated 18–22% upside by March 2028.

seekingalpha.com - 2026-07-04 11:39:12

McKesson's growth in specialty pharma, oncology services and tech-driven solutions is boosting earnings, but policy and execution risks remain in focus.

zacks.com - 2026-07-02 15:16:23

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-07-02 10:46:05

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-30 10:52:15

McKesson (MCK) concluded the recent trading session at $747.53, signifying a -2.09% move from its prior day's close.

zacks.com - 2026-06-29 18:51:09

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-26 10:41:15

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-06-24 10:00:30

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services lea.

businesswire.com - 2026-06-24 08:00:00

IRVING, Texas--(BUSINESS WIRE)--Last week, McKesson Corporation hosted McKesson ideaShare 2026, the company's annual event for independent community pharmacies, in Denver, Colorado.

businesswire.com - 2026-06-23 08:00:00

McKesson (MCK) closed the most recent trading day at $750.63, moving 3.74% from the previous trading session.

zacks.com - 2026-06-18 18:51:19

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

zacks.com - 2026-06-10 10:01:24

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-06-09 10:41:15

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-08 10:51:21

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today the successful completion of the previously announced minority ownership interest investment from funds managed by affiliates of Apollo (“Apollo Funds”) in McKesson's Medical-Surgical Solutions (“MMS”) business on June 1, 2026. This transaction represents a key milestone in McKesson's intention to separate MMS into an independent, publicly traded company, and positions the business for long-term growth. Apollo Fund.

businesswire.com - 2026-06-02 08:00:00

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

zacks.com - 2026-05-27 10:00:26

McKesson's oncology growth, GLP-1 momentum and RxTS expansion support earnings strength, but pricing reform and margin pressures pose risks.

zacks.com - 2026-05-22 13:21:07

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

zacks.com - 2026-05-14 10:01:34

McKesson Corporation (MCK) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-12 15:10:48

McKesson NYSE: MCK reported a stronger fiscal fourth quarter and full fiscal 2026 performance, with executives pointing to growth across its oncology, multispecialty, pharmaceutical distribution and prescription technology businesses, while outlining plans for continued earnings growth in fiscal 2027.

marketbeat.com - 2026-05-11 15:09:43

McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.

zacks.com - 2026-05-08 11:51:07

McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-07 21:01:17

Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com - 2026-05-07 19:01:13

McKesson (MCK) came out with quarterly earnings of $11.69 per share, beating the Zacks Consensus Estimate of $11.56 per share. This compares to earnings of $10.12 per share a year ago.

zacks.com - 2026-05-07 18:55:12

McKesson forecast 2027 profit slightly above Wall Street expectations after beating first-quarter profit estimates ​on Thursday, as the U.S. drug distributor ‌banks on strength in its oncology and specialty drug businesses.

reuters.com - 2026-05-07 17:50:15

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 7, at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arch.

businesswire.com - 2026-05-07 16:10:00

MCK heads into Q4 earnings with strength in oncology, GLP-1 demand, and biopharma services, but softer medical-surgical trends may weigh.

zacks.com - 2026-05-07 14:35:45

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2026.

zacks.com - 2026-05-04 10:16:25

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-30 11:06:47

McKesson (MCK) closed the most recent trading day at $822.63, moving 1.48% from the previous trading session.

zacks.com - 2026-04-29 18:51:24

Concurrent Investment Advisors LLC grew its position in McKesson Corporation (NYSE: MCK) by 62.9% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,158 shares of the company's stock after buying an additional 1,219 shares during the quarter. Concurrent Investment Advisors LLC's

defenseworld.net - 2026-04-29 14:10:49

William Blair launched coverage of Cardinal Health (NYSE:CAH | CAH Price Prediction) with an Outperform rating today, framing the pharma distributor as a durable franchise with specialty-led upside.

247wallst.com - 2026-04-28 11:55:52

Launched on November 24, 2015, the Xtrackers Russell US Multifactor ETF (DEUS) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.

zacks.com - 2026-04-28 07:20:31

Somehow, members of Congress have turned relatively modest salaries into impressive investment portfolios while the rest of us grind it out in the market.

247wallst.com - 2026-04-25 08:23:00

Calamos Advisors LLC decreased its holdings in shares of McKesson Corporation (NYSE: MCK) by 3.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,545 shares of the company's stock after selling 1,237 shares during the period. Calamos Advisors LLC's holdings

defenseworld.net - 2026-04-25 03:58:52

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

zacks.com - 2026-04-24 10:01:42

Arizona State Retirement System decreased its holdings in shares of McKesson Corporation (NYSE: MCK) by 3.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,293 shares of the company's stock after selling 1,266 shares during the quarter. Arizona State Retirement

defenseworld.net - 2026-04-24 03:50:43

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on July 1, 2026, to shareholders of record on June 1, 2026. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers,.

businesswire.com - 2026-04-22 08:00:00

The latest trading day saw McKesson (MCK) settling at $842.25, representing a -1.95% change from its previous close.

zacks.com - 2026-04-21 19:01:35

McKesson's net earnings increased at an average rate of 14.4% over the previous three years, while its earnings per share (EPS) grew by 19.6% annually in that same period. This 5.2% disparity indicates the additional value management has successfully secured for shareholders through a steadfast approach.

forbes.com - 2026-04-21 12:26:13

DSG Capital Advisors LLC raised its position in McKesson Corporation (NYSE: MCK) by 52.9% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,400 shares of the company's stock after purchasing an additional 830 shares during the quarter. DSG Capital Advisors

defenseworld.net - 2026-04-21 05:08:44

McKesson said Apollo affiliates agreed to buy a minority ownership interest in its medical-surgical solutions business ahead of the unit's planned spinoff.

wsj.com - 2026-04-20 08:58:00

McKesson said on Monday ‌it will sell a minority stake in its medical-surgical solutions business to investment firm ​Apollo Funds for $1.25 billion, as it prepares ​to spin off the unit through ⁠an initial public offering.

reuters.com - 2026-04-20 08:34:48